ATE277191T1 - Retrovirale vektoren für die transduktion des beta-globingens, sowie derivaten der beta-ort kontrollierten region des beta-orts - Google Patents

Retrovirale vektoren für die transduktion des beta-globingens, sowie derivaten der beta-ort kontrollierten region des beta-orts

Info

Publication number
ATE277191T1
ATE277191T1 AT94920181T AT94920181T ATE277191T1 AT E277191 T1 ATE277191 T1 AT E277191T1 AT 94920181 T AT94920181 T AT 94920181T AT 94920181 T AT94920181 T AT 94920181T AT E277191 T1 ATE277191 T1 AT E277191T1
Authority
AT
Austria
Prior art keywords
beta
location
retroviral vectors
gene
derivatives
Prior art date
Application number
AT94920181T
Other languages
English (en)
Inventor
Philippe Leboulch
Irving M London
Dorothy Tuan
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Application granted granted Critical
Publication of ATE277191T1 publication Critical patent/ATE277191T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Road Signs Or Road Markings (AREA)
AT94920181T 1993-06-11 1994-06-10 Retrovirale vektoren für die transduktion des beta-globingens, sowie derivaten der beta-ort kontrollierten region des beta-orts ATE277191T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/076,090 US5631162A (en) 1993-06-11 1993-06-11 Retroviral vectors for transducing β-globin gene and β-locus control region derivatives
PCT/US1994/006661 WO1994029470A1 (en) 1993-06-11 1994-06-10 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives

Publications (1)

Publication Number Publication Date
ATE277191T1 true ATE277191T1 (de) 2004-10-15

Family

ID=22129871

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94920181T ATE277191T1 (de) 1993-06-11 1994-06-10 Retrovirale vektoren für die transduktion des beta-globingens, sowie derivaten der beta-ort kontrollierten region des beta-orts

Country Status (8)

Country Link
US (1) US5631162A (de)
EP (1) EP0706575B1 (de)
JP (1) JPH09501046A (de)
AT (1) ATE277191T1 (de)
CA (1) CA2164953A1 (de)
DE (1) DE69434022T2 (de)
ES (1) ES2231774T3 (de)
WO (1) WO1994029470A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE181361T1 (de) * 1994-09-19 1999-07-15 Massachusetts Inst Technology Anti-sickling beta-globin,zusammensetzung und verfahren zur behandlung von sichelzellanämie
EP0835320A1 (de) * 1995-05-10 1998-04-15 Introgene B.V. Verbesserte retroviralen vektoren, besonders angepasst zur gen-therapie
DK0918874T3 (da) * 1996-08-16 2001-05-14 Medical Res Council Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspression
GB9720465D0 (en) 1997-09-25 1997-11-26 Oxford Biomedica Ltd Dual-virus vectors
GB2344592B (en) * 1997-09-25 2002-09-11 Oxford Biomedica Ltd Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
CA2246005A1 (en) * 1998-10-01 2000-04-01 Hsc Research And Development Limited Partnership Hybrid genes for gene therapy in erythroid cells
GB9906615D0 (en) * 1999-03-22 1999-05-19 Oxford Biomedica Ltd Vector
GB9910664D0 (en) * 1999-05-07 1999-07-07 Zeneca Ltd Cells and assay
EP1409025B1 (de) * 2001-06-29 2011-11-30 Sloan Kettering Institute For Cancer Research Vektor kodierend humanes globin-gen und seine verwendung bei der behandlung von hämoglobinopathien
CN103403151A (zh) * 2011-01-03 2013-11-20 蓝鸟生物公司 提高基因转导的细胞的递送的方法
WO2014162318A2 (en) * 2013-03-30 2014-10-09 Usha Biotech Limited Methods and constructs for expressing biologically active proteins in mammalian cells

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8718779D0 (en) * 1987-08-07 1987-09-16 Grosveld F G Dna sequence & expression vector
JP2779192B2 (ja) * 1987-09-17 1998-07-23 マサチユセツツ・インスチチユート・オブ・テクノロジー ヒト赤血球特異的転写エンハンサー

Also Published As

Publication number Publication date
CA2164953A1 (en) 1994-12-22
EP0706575A1 (de) 1996-04-17
ES2231774T3 (es) 2005-05-16
EP0706575B1 (de) 2004-09-22
DE69434022D1 (de) 2004-10-28
WO1994029470A1 (en) 1994-12-22
DE69434022T2 (de) 2005-08-18
JPH09501046A (ja) 1997-02-04
US5631162A (en) 1997-05-20

Similar Documents

Publication Publication Date Title
ATE277191T1 (de) Retrovirale vektoren für die transduktion des beta-globingens, sowie derivaten der beta-ort kontrollierten region des beta-orts
ATE341638T1 (de) Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
ATE298371T1 (de) Nicht-primaten lentivirale vektoren und verpackungssysteme
GB2331522A (en) Lentiviral vectors
AU599091B2 (en) Expression and purification of an htlv-iii gag/env gene protein
RO90639B (ro) Procedeu pentru prepararea tesutului uman activator de plasminogen
DE69435316D1 (de) Verfahren zur herstellung von hohen virustitern und die hocheffiziente transduktion von säugerzellen durch retroviren
GR3004707T3 (de)
EP1683871A3 (de) Nukleinsäureliganden und ihre Herstellungsmethoden
ZA968382B (en) Vector and method of use for nucleic acid delivery to non-dividing cells
WO1997007225A3 (en) High efficiency retroviral packaging system
HUP9801697A2 (hu) Új protein és eljárás előállítására
AU4776585A (en) Molecular clones of the genome of htlv-iii
AU5233686A (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
EP0424416A4 (en) Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex
EP0759471A4 (de) Rekombinanter vektor bestehend aus dem menschlichen immunschwäche-virus und verfahren zu seiner herstellung
DK336688D0 (da) Nucleosider od fremgangsmaade til fremstilling deraf
NO970325L (no) Fremgangsmåte for fremstilling av biologisk aktivt dimerisk protein
ATE112317T1 (de) Bcrf1-proteine als inhibitoren von interferon- g(g).
ES8900170A1 (es) Procedimiento de modificacion de celulas eucariotas.
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
EP0394386A4 (en) Method for producing native hiv gp160
ES2052826T3 (es) Procedimiento de resolucion enzimatica.
DK95188A (da) Dna-segment, som fremkalder hoejfrekvens-transduktion af rekombinant-rna-vektorer
AU3905893A (en) Plant resistant to two or more viruses and preparation thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties